Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. - Wikidata - wikimedia - TriplyDB

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.

http://www.wikidata.org/entity/Q46810913

about

Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)Biomarkers of Alzheimer's disease Untangling tau imaging Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT Insight into the Molecular Imaging of Alzheimer's Disease Role of Hybrid Brain Imaging in Neuropsychiatric Disorders Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging Brain imaging in Alzheimer disease Clinical and research applications of simultaneous positron emission tomography and MRI PET probes beyond (18)F-FDG Amyloid PET in clinical practice: Its place in the multidimensional space of Alzheimer's disease Brain PET in the diagnosis of Alzheimer's disease Development of positron emission tomography β-amyloid plaque imaging agents Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease 18F-florbetaben Aβ imaging in mild cognitive impairment Florbetaben for PET Imaging of Beta-Amyloid Plaques in the Brain Beta-amyloid deposition and the aging brain Metabolite profiling of Alzheimer's disease cerebrospinal fluid Quantitative amyloid imaging using image-derived arterial input function PET amyloid-beta imaging in preclinical Alzheimer's disease Biomarkers for cognitive impairment and dementia in elderly people.Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings Advances in CNS Imaging Agents: Focus on PET and SPECT Tracers in Experimental and Clinical Use.Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models.Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer׳s disease Current and future uses of neuroimaging for cognitively impaired patients.Self-reported confusion is related to global and regional β-amyloid: data from the Women's healthy ageing project.Cerebellum and psychiatric disorders.Imaging in Alzheimer's disease.Recent Progress in Alzheimer's Disease Research, Part 3: Diagnosis and Treatment.Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.18F stilbenes and styrylpyridines for PET imaging of A beta plaques in Alzheimer's disease: a miniperspective.Communicating mild cognitive impairment diagnoses with and without amyloid imaging.Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates Optimized classification of 18F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment.Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.Alzheimer's prevention initiative: a proposal to evaluate presymptomatic treatments as quickly as possible.Diagnosis and biomarkers of predementia in Alzheimer's disease.

P2860

Q22251077-6D1CC3BD-EC86-4D85-9568-535A68155DDD Q24630918-ABF31C44-DE07-4C9B-BDCF-74EFA84F1287 Q24650667-E6B5396B-66A5-47F3-B760-C0C216B5FC03 Q26739091-3A345D35-155C-425D-8EC3-1266FC6956C3 Q26749755-92A0C136-3F78-4021-ADD6-D1C832938CDB Q26765945-8FADB533-633E-43FD-84E8-945C827CDC08 Q26768454-6D7D9F46-CD32-496C-B519-C5D13BB8DB50 Q26770766-7C9F94ED-6BD3-4337-A3CA-0DDF01CDEA9C Q26996299-CAC75E1F-7CA7-4DC7-A9B7-F4D0A85F0F07 Q26998774-FE087F70-10B8-4FCD-B2D0-C12D560B2F99 Q27004457-099D63DE-4803-46FD-B66B-8EBFCED47A89 Q27009411-AE25B972-C16F-4865-A7CD-07B4C19AD188 Q27011549-0E457C68-5980-4C5C-87AF-E85F8812CBC6 Q27012742-97993343-0161-41AF-B575-0D56F4E7F7F6 Q27027319-DFA11EE3-E59C-439D-94C7-7C60602C3776 Q27499311-10570BC1-086F-45BC-BC0D-F74CC72F270B Q28085541-71BD80CD-76C1-45B5-B56E-3611CC2907BC Q28264556-83432A03-8415-4263-87A9-903EB93CDCA3 Q28480903-284B591E-2972-43F9-BB13-1F6256EC2264 Q28545789-583272F1-F268-4798-A837-BA98D6297CCA Q30040695-FB98A0DA-819A-4986-8807-40819F013552 Q30370745-7373A143-FBC4-4629-A213-DC520D621092 Q30666527-5A9AF5F6-AA5E-4437-86F3-205102EF4363 Q30945416-93DBDC0B-FDAD-4844-A2E1-75A674BC40A6 Q30996675-55AC303B-6324-4DDF-8F30-003DC2A003E6 Q31025427-6E498411-7FBB-422A-B395-F88727F99D0A Q31143267-659339E0-2E55-4124-ABC1-2051F1FE6F70 Q31155701-309811F0-00E2-4362-A130-878888D1EEB1 Q33373705-3A9DB604-71C3-4EB4-B3F3-C832354A1853 Q33479675-41DC8A20-E2FC-4CF5-A413-B1BBB83B13EF Q33556068-ED355812-99C6-4B00-8606-039C109C380A Q33590723-ADDF859C-1331-468D-96E0-536F0287711A Q33637211-9DF8159E-7770-4849-87D6-68AC15F4530B Q33640373-E9AC15FD-F673-4982-A3D7-676902F7786E Q33654396-42BA6B75-AEEE-4772-88D0-A70BC3BFFD9F Q33683377-72FEBB29-9805-47BF-BD0B-38B76D9B6FD5 Q33714693-EA0280E3-53C9-4F82-8E80-2DFD784ED4F2 Q33747987-1D71C78A-AF4D-42B6-9108-835363D8658A Q33773031-BC04551F-1FFF-4902-B419-B65DE051BF13 Q33777509-7B8B42DD-70DD-401F-9740-19C5191D1AE0

P2860

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism.

http://www.wikidata.org/entity/Q46810913

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Imaging of amyloid beta in Alz ...... ET tracer: proof of mechanism.

@en

Imaging of amyloid beta in Alz ...... ET tracer: proof of mechanism.

@nl

type

label

Imaging of amyloid beta in Alz ...... ET tracer: proof of mechanism.

@en

Imaging of amyloid beta in Alz ...... ET tracer: proof of mechanism.

@nl

prefLabel

Imaging of amyloid beta in Alz ...... ET tracer: proof of mechanism.

@en

Imaging of amyloid beta in Alz ...... ET tracer: proof of mechanism.

@nl

P1433

Q46810913-3543BAC2-2D07-4048-895A-476FBEE8916F

P1476

Q46810913-62800EA2-F15B-4F60-AD91-3ABBBAF5DE92

P2093

Q46810913-2613BAAD-38C2-4041-ACBA-103C3F3BE084

Q46810913-30CBE083-C22B-41D9-9C86-6016D0FA0CBD

Q46810913-3941A83C-AFA4-433C-B89E-D922BA4FE191

Q46810913-46A1D4D1-1590-4A2A-A57E-ECAD489724AB

Q46810913-47ECD453-8057-4053-B9B6-4A7BCE344856

Q46810913-4B53E93C-1F68-4655-97B4-60E218114F06

Q46810913-5BD902F5-07E8-4955-895B-70CB286C514A

Q46810913-75CACD45-C878-4E99-A618-6DD253B83707

Q46810913-760C07BE-96AA-4AE8-91C4-5EA4F6A5DB88

Q46810913-93376616-C2AE-4E03-A8F8-FE3F5941DE14

P304

Q46810913-6FA521B8-4E46-4F00-90D9-BB6FD184D4E1

P31

Q46810913-4A12DF9E-FFCB-48C0-831E-54C20C8A5D41

P356

Q46810913-56F75433-09CB-4AC8-B8DD-04D5034B5A04

P433

Q46810913-095E2413-0DBF-43D8-AAD0-0DBA18ED3E78

P478

Q46810913-202194A7-5382-4FEB-950F-71C2692C13FA

P50

Q46810913-6554D588-16BD-4666-BD05-97F3101109E7

Q46810913-6FE0F6B5-B412-4BDC-B57D-2F15E3708D54

Q46810913-C65EAB7C-6B25-42EB-8B43-46A3D49CD284

P577

Q46810913-A46E0D70-A93E-4C15-8ED9-6B4C3541674E

P698

Q46810913-FF71A12D-DB41-43E3-83C8-E01EDA15FCA8

P921

Q46810913-749EA75F-BC60-41E5-850D-7D3494C194C3

Q46810913-D824B1D7-3158-4422-BA96-BE073F0CADC2

P356

S1474-4422(08)70001-2

P1433

Lancet Neurology

P1476

Imaging of amyloid beta in Alz ...... ET tracer: proof of mechanism.

@en

P2093

Christopher C Rowe

http://www.w3.org/2001/XMLSchema#string

Daniel Skovronsky

http://www.w3.org/2001/XMLSchema#string

Gerhard Holl

http://www.w3.org/2001/XMLSchema#string

Gordon Chan

http://www.w3.org/2001/XMLSchema#string

Graeme O'Keefe

http://www.w3.org/2001/XMLSchema#string

Hank P Kung

http://www.w3.org/2001/XMLSchema#string

Henry Tochon-Danguy

http://www.w3.org/2001/XMLSchema#string

Kerryn L Dickinson-Rowe

http://www.w3.org/2001/XMLSchema#string

Ludger M Dinkelborg

http://www.w3.org/2001/XMLSchema#string

Lutz Lehman

http://www.w3.org/2001/XMLSchema#string

P304

129-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1474-4422(08)70001-2

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Colin L. Masters

Gareth R. Jones

P577

2008-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18191617

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

florbetaben f-18